Skip to main content
. 2009 Feb 15;64(5):945–952. doi: 10.1007/s00280-009-0946-4

Fig. 1.

Fig. 1

Disease-specific survival. Kaplan–Meier estimates of disease-specific survival in stage III and IV. Two-year disease-specific survival rates were 92% in stage III and 38% in stage IV. There was a significant difference between the two groups (P = 0.039)